A rapid, simple and validated reversed-phase high-performance liquid chromatographic method has been developed for analysis of oxaprozin in pharmaceutical dosage forms. Oxaprozin was separated on an ODS analytical column with a 45:55 (v/v) mixture of acetonitrile and triethanolamine solution (5 mm, pH 3.5 ± 0.05, adjusted by addition of 85% phosphoric acid) as mobile phase at a flow rate of 2.0 mL min–1. The effluent was monitored by UV detection at 254 nm. Calibration plots were linear in the range 160 to 240 μg mL–1 and the LOD and LOQ were 14.26 and 41.21 μg mL–1, respectively. The high recovery and low relative standard deviation confirm the suitability of the method for routine QC determination of oxaprozin in tablets.
[1]. Merck Research Laboratories 2001 The Merck Index, An Encyclopedia of Chemical, Drugs, and Biologicals 11th edn Merck Research Laboratories Whitehouse Station, NJ, 6879, USA 1095.
[3]. K.V.S.R.K. Reddy D.S. Rao K. Vyas G.O. Reddy 2000 J. Pharm. Biomed. Anal. 22 651.
[4]. D.M. Pierce 1981 Xenobiotica 11 857.
[5]. F.W. Janssen S.K. Kirkman J.A. Knowles H.W. Ruelius 1978 Drug Metab. Dispos. 6 465.
[6]. L.S. McHugh S.K. Kirkman J.A. Knowles A. John 1980 J. Pharm. Sci. 69 794.
[7]. R. Matlis D.J. Greenblat 1984 J. Chromatogr. 445 310.
[8]. M. Kruowski H. Thobe 1989 Agents Actions 27 458.
[9]. J.B. Gao W. Hae N.N. Zhang W. Wang 2003 Chin. J. Pharm. 33 3 132.
[10]. J.D. Johnson G.E. Van Buskirk 1998 J. Valid. Technol. 2 88.
[11]. L.R. Snyder J.J. Kirkland J.L. Glajch 1988 Practical HPLC Method Development Wiley-Interscience New York 402.
[12]. International Conference on the Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Q2B (1996). Validation of Analytical Procedures, Methodology, pp. 1–8.
[13]. US Pharmacopoeial Convention, United States Pharmacopoeia, 28th edn, US Pharmacopoeial Convention, Rockville, MD, 2005, pp. 1196–1198.
[14]. FDA: Guidance for Industry, Analytical Procedures and Methods Validation, 2000.